Clinical Trials · NCT04797338

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

UnknownPhase 4Gonadorelin (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
Assaf-Harofeh Medical Center
Enrollment
100
Start date
Dec 2017
Locations
1 site, Israel
Primary endpoint
clinical pregnancy rate
View Gonadorelin compound reference